uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report.
Show others and affiliations
2016 (English)In: Neuromuscular Disorders, ISSN 0960-8966, E-ISSN 1873-2364Article in journal (Refereed) Epub ahead of print
Abstract [en]

Myasthenia gravis (MG) is an autoimmune disease, with immune reactivity against the post-synaptic endplate of the neuromuscular junction. Apart from symptomatic treatment with choline esterase blockers, many patients also require immunomodulatory treatment. Despite existing treatment options, some patients are treatment refractory. We describe a patient with severe MG refractory to corticosteroids, four oral immunosuppressants, cyclophosphamide, rituximab and bortezomib who was treated with autologous haematopoietic stem cell transplantation. Two years after this, the patient has significantly improved in objective tests and in quality of life and leads an active life. Diplopia is her only remaining symptom and she is completely free of medication for MG. We believe that autologous haematopoietic stem cell transplantation can be an effective therapeutic option for carefully selected cases of severe, treatment refractory MG.

Place, publisher, year, edition, pages
2016.
Identifiers
URN: urn:nbn:se:uu:diva-310817DOI: 10.1016/j.nmd.2016.09.020PubMedID: 27863874OAI: oai:DiVA.org:uu-310817DiVA: diva2:1058011
Available from: 2016-12-20 Created: 2016-12-20 Last updated: 2016-12-20

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Carlson, KristinaHägglund, Hans
By organisation
Haematology
In the same journal
Neuromuscular Disorders

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 34 hits
ReferencesLink to record
Permanent link

Direct link